Adaptive Clinical Trials: The Promise and the Caution

被引：129

作者：

Berry, Donald A. ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 06期

关键词：

CANCER; DESIGN;

D O I：

10.1200/JCO.2010.32.2685

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：606 / 609

页数：5

共 19 条

[1]

[Anonymous], 2010, ADAPTIVE DESIGN CLIN

[2] I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy [J].

Barker, A. D. ;

Sigman, C. C. ;

Kelloff, G. J. ;

Hylton, N. M. ;

Berry, D. A. ;

Esserman, L. J. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (01) :97-100

[3] Bayesian clinical trials [J].

Berry, DA .

NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (01) :27-36

[4] Introduction to Bayesian methods III: use and interpretation of Bayesian tools in design and analysis [J].

Berry, DA .

CLINICAL TRIALS, 2005, 2 (04) :295-300

[5]

Berry DA, 2009, HOLLAND FREI CANC ME, P446

[6] The Hazards of Endpoints [J].

Berry, Donald A. .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (18) :1376-1377

[7] Bayesian clinical trials at the University of Texas M. D. Anderson Cancer Center [J].

Biswas, Swati ;

Liu, Diane D. ;

Lee, J. Jack ;

Berry, Donald A. .

CLINICAL TRIALS, 2009, 6 (03) :205-216

[8]

Chalmers I., 2010, JLL Bulletin

[9]

CHALMERS I, 2006, JA BELL BIRTH RANDOM

[10]

COOK JD, 2007, 39 DEP BIOST UT MD A

← 1 2 →